HRS §329-1 Definitions
329-1. Definitions
As used in this chapter:
"Abuse" means the misuse of a
substance or the use of a substance to an extent deemed deleterious or
detrimental to the user, to others, or to society.
"Address" means, with respect to
prescriptions, the physical location where an individual resides, such as:
(1) Street address, city,
and state;
(2) Tax map key number; or
(3) The description of a
physical location.
Unless the context dictates otherwise,
"address" includes a post office box; provided that the pharmacy
dispensing the prescription has, on file, the physical location where an
individual resides.
"Administer" means the direct
application of a controlled substance, whether by injection, inhalation,
ingestion, or any other means, to the body of a patient or research subject by:
(1) A practitioner (or, in
the practitioner's presence or at the practitioner's direction, by a licensed
or registered health care professional acting as the practitioner's authorized
agent), or
(2) The patient or
research subject at the direction or in the presence of the practitioner.
"Administrator" [Definition
effective until December 31, 2023. For definition effective January 1, 2024,
see below.] means the administrator of the narcotics enforcement division
of the department of public safety.
"Administrator" [Definition
effective January 1, 2024. For definition effective until December 31, 2023,
see above.] means the administrator of the narcotics enforcement division
of the department of law enforcement.
"Advanced practice registered nurse with
prescriptive authority" means a person licensed under section 457-8.6 who
is registered under this chapter to administer or prescribe a controlled
substance; provided that an advanced practice registered nurse with
prescriptive authority shall not be authorized to request, receive, or sign for
professional controlled substance samples.
"Agent" means an authorized person
who acts on behalf of or at the direction of a manufacturer, distributor, or
dispenser. It does not include a common or contract carrier, public
warehouseman, or employee of the carrier or warehouseman.
"Bureau" or "DEA" means the
Drug Enforcement Administration, United States Department of Justice, or its
successor agency.
"Central fill pharmacy" means a
pharmacy located in the State that is registered pursuant to section 329-32 to
prepare controlled substance orders for dispensing to the ultimate user
pursuant to a valid prescription transmitted to it by a registered pharmacy.
"Central repository" means a central
repository established under section 329-102.
"Controlled substance" means a drug,
substance, or immediate precursor in schedules I through V of part II.
"Counterfeit substance" means a
controlled substance which, or the container or labeling of which, without
authorization, bears the trademark, trade name, or other identifying mark,
imprint, number or device, or any likeness thereof, of a manufacturer,
distributor, or dispenser other than the person who in fact manufactured,
distributed, or dispensed the substance.
"Deliver" or "delivery"
means the actual, constructive, or attempted transfer or sale from one person
to another of a controlled substance or drug paraphernalia, whether or not
there is an agency relationship.
"Department" [Definition effective
until December 31, 2023. For definition effective January 1, 2024, see below.]
means the department of public safety.
"Department" [Definition effective
January 1, 2024. For definition effective until December 31, 2023, see above.]
means the department of law enforcement.
"Designated member of the health care
team" includes physician assistants, advanced practice registered nurses,
and covering physicians who are authorized under state law to prescribe drugs.
"Designated state agency" [Definition effective until December 31, 2023. For
definition effective January 1, 2024, see below.] means the narcotics
enforcement division, department of public safety.
"Designated state agency" [Definition
effective January 1, 2024. For definition effective until December 31, 2023,
see above.] means the narcotics enforcement division, department of law enforcement.
"Detoxification treatment" means the
dispensing, for a specific period of time, of a narcotic drug or narcotic drugs
in decreasing doses to an individual to alleviate adverse physiological or
psychological effects incident to withdrawal from the continuous or sustained
use of a narcotic drug and as a method of bringing the individual to a narcotic
drug-free state within a specified period of time. There are two types of
detoxification treatments: short-term detoxification treatment and long-term
detoxification treatment;
(1) Short-term
detoxification treatment is for a period not in excess of thirty days; and
(2) Long-term
detoxification treatment is for a period more than thirty days but not in
excess of one hundred eighty days.
"Dispense" means to deliver a
controlled substance to an ultimate user or research subject by or pursuant to
the lawful order of a practitioner, including the administering of a
practitioner's controlled substances, and packaging, labeling, or compounding
necessary to prepare the substance for that delivery. A controlled substance
is dispensed when:
(1) It is compounded,
prepared, labeled, and packaged pursuant to the lawful order of a practitioner
by a licensed pharmacist acting in the usual course of the licensed
pharmacist's professional practice and who is either registered individually or
employed in a registered pharmacy or by a registered institutional
practitioner, for delivery to the ultimate user;
(2) It is compounded,
prepared, labeled and packaged for delivery to the ultimate user by a
practitioner acting in the usual course of the practitioner's professional
practice;
(3) It is prepared,
labeled, and packaged pursuant to the lawful order of a practitioner by a
registered health care professional acting as an agent of the practitioner for
delivery to the ultimate user by the practitioner; or
(4) It is prepackaged by a
pharmacist for use in an emergency facility for delivery to the ultimate user
by a licensed or registered health care professional pursuant to the order of a
physician.
"Dispenser" means a practitioner who
dispenses.
"Distribute" means to deliver other
than by administering or dispensing a controlled substance.
"Distributor" means a person who
distributes.
"Drug" means:
(1) Substances recognized
as drugs in the official United States Pharmacopoeia, official Homeopathic
Pharmacopoeia of the United States, or official National Formulary, or any
supplement to any of them;
(2) Substances intended
for use in the diagnosis, cure, mitigation, treatment, or prevention of disease
in man or animals;
(3) Substances (other than
food) intended to affect the structure or any function of the body of man or
animals; and
(4) Substances intended
for use as a component of any article specified in clause (1), (2), or (3) of
this subsection. It does not include devices or their components, parts, or
accessories.
"Drug Enforcement Administration
registration number" means the practitioner's Drug Enforcement
Administration controlled substance registration number.
"Drug paraphernalia" means all
equipment, products, and materials of any kind that are used, primarily
intended for use, or primarily designed for use, in planting, propagating,
cultivating, growing, harvesting, manufacturing, compounding, converting,
producing, processing, preparing, testing, analyzing, packaging, repackaging,
storing, containing, concealing, injecting, ingesting, inhaling, or otherwise
introducing into the human body a controlled substance in violation of this
chapter. Drug paraphernalia includes but is not limited to:
(1) Kits used, primarily
intended for use, or primarily designed for use in planting, propagating,
cultivating, growing, or harvesting of any species of plant that is a
controlled substance or from which a prohibited controlled substance can be
derived;
(2) Kits used, primarily
intended for use, or primarily designed for use in manufacturing, compounding,
converting, producing, processing, or preparing prohibited controlled
substances;
(3) Isomerization devices
used, primarily intended for use, or primarily designed for use in increasing
the potency of any species of plant that is a prohibited controlled substance;
(4) Testing equipment
used, primarily intended for use, or primarily designed for use in identifying,
or in analyzing the strength, effectiveness, or purity of prohibited controlled
substances;
(5) Scales and balances
used, primarily intended for use, or primarily designed for use in weighing or
measuring prohibited controlled substances;
(6) Diluents and
adulterants; such as quinine hydrochloride, mannitol, mannite, dextrose, and
lactose, used, primarily intended for use, or primarily designed for use in
cutting prohibited controlled substances;
(7) Separation gins and
sifters used, primarily intended for use, or primarily designed for use in
removing twigs and seeds from, or in otherwise cleaning or refining, prohibited
marijuana;
(8) Blenders, bowls,
containers, spoons, and mixing devices used, primarily intended for use, or
primarily designed for use in compounding prohibited controlled substances;
(9) Capsules, balloons,
envelopes, and other containers used, primarily intended for use, or primarily
designed for use in packaging small quantities of prohibited controlled
substances;
(10) Containers and other
objects used, primarily intended for use, or primarily designed for use in
storing or concealing prohibited controlled substances;
(11) Hypodermic syringes,
needles, and other objects used, primarily intended for use, or primarily
designed for use in parenterally injecting prohibited controlled substances
into the human body;
(12) Objects used,
primarily intended for use, or primarily designed for use in ingesting,
inhaling, or otherwise introducing prohibited marijuana, cocaine, hashish,
hashish oil, or methamphetamine into the human body, such as:
(A) Metal, wooden,
acrylic, glass, stone, plastic, or ceramic pipes with or without screens,
permanent screens, hashish heads, or punctured metal bowls;
(B) Water pipes;
(C) Carburetion
tubes and devices;
(D) Smoking and
carburetion masks;
(E) Roach clips:
meaning objects used to hold burning materials, such as marijuana cigarettes,
that have become too small or too short to be held in the hand;
(F) Miniature
cocaine spoons, and cocaine vials;
(G) Chamber pipes;
(H) Carburetor
pipes;
(I) Electric
pipes;
(J) Air-driven
pipes;
(K) Chillums;
(L) Bongs; and
(M) Ice pipes or
chillers.
In determining whether an object is drug
paraphernalia, a court or other authority should consider, in addition to all
other logically relevant factors, the following:
(1) Statements by an owner
or anyone in control of the object concerning its use;
(2) Prior convictions, if
any, of an owner, or of anyone in control of the object, under any state or
federal law relating to any controlled substance;
(3) The proximity of the
object, in time and space, to a direct violation of this chapter;
(4) The proximity of the
object to controlled substances;
(5) The existence of any
residue of controlled substances on the object;
(6) Direct or
circumstantial evidence of the intent of an owner, or anyone in control of the
object, to deliver it to a person or persons whom the owner or person in
control knows, or should reasonably know, intend to use the object to
facilitate a violation of this chapter; provided that the innocence of an owner,
or of anyone in control of the object, as to a direct violation of this chapter
shall not prevent a finding that the object is intended for use, or designed
for use, as drug paraphernalia;
(7) Instructions, oral or
written, provided with the object concerning its use;
(8) Descriptive materials
accompanying the object that explain or depict its use;
(9) National and local
advertising concerning its use;
(10) The manner in which
the object is displayed for sale;
(11) Whether the owner, or
anyone in control of the object, is a legitimate supplier of like or related
items to the community, such as a licensed distributor or dealer of tobacco
products;
(12) Direct or
circumstantial evidence of the ratio of sales of the object or objects to the
total sales of the business enterprise;
(13) The existence and
scope of legitimate uses for the object in the community; and
(14) Expert testimony
concerning its use.
"Drug paraphernalia" does not include
fentanyl test strips.
"Electronic prescription" means a
prescription that is generated on an electronic prescription application and
transmitted as an electronic data file that complies with all applicable
requirements of title 21 Code of Federal Regulations part 1311 and any
additional rules adopted by the department.
"Electronic prescription application"
means electronic prescription software either as a stand-alone application or
as a module in an electronic health record application.
"Electronic signature" means a method
of signing an electronic message that identifies a particular person as the
source of the message and indicates the person's approval of the information
contained in the message.
"Ephedrine" includes any synthetic
compound, salt, derivative, mixture, or preparation extracted from the plant
(genus) Ephedra that contains the substance ephedrine.
"Exception report" means an output of
data indicating schedule II controlled substances dispensation that is outside
expected norms for a practitioner practicing a particular specialty or field of
health care, for a dispenser doing business in a particular location, or for a
patient.
"Fentanyl test strip" means a small
strip of paper that can detect the presence of fentanyl in:
(1) Different kinds of
drugs, including cocaine, methamphetamine, and heroin; and
(2) Different drug forms,
such as pills, powder, and injectable drugs.
"Hemp" [Definition repealed July
1, 2027. L 2023, c 263, §15.] means all parts of the plant cannabis
sativa L., whether growing or not, including the seeds thereof and all
derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of
isomers, with a delta-9-tetrahydrocannabinol concentration of not more than 0.3
per cent on a dry weight basis, as measured post-decarboxylation or other
similarly reliable methods.
"Identification number" means, with
respect to a patient:
(1) The patient's unique
valid driver's license number or state identification card number, followed by
the abbreviation of the state issuing the driver's license or state
identification card, or the patient's military identification number;
(2) If the patient is a foreign patient, the
patient's passport number;
(3) If the patient does not have a valid
driver's license, state identification card, or military identification, the
patient's social security number;
(4) If the patient is less than eighteen
years of age and has none of the identification referred to in paragraph (1),
(2), or (3), the unique number on the valid driver's license, state
identification card, military identification, or passport of the patient's
parent or guardian; or
(5) If the controlled
substance is obtained for an animal, the unique number of the animal's owner as
described in paragraph (1), (2), or (3).
"Immediate precursor" [Definition
effective until December 31, 2023. For definition effective January 1, 2024,
see below.] means a substance which the department of public safety has
found to be and by rule designates as being the principal compound commonly
used or produced primarily for use, and which is an immediate chemical
intermediary used or likely to be used in the manufacture of a controlled
substance, the control of which is necessary to prevent, curtail, or limit
manufacture.
"Immediate precursor" [Definition effective January 1, 2024. For definition
effective until December 31, 2023, see above.] means a substance which
the department of law enforcement has found to be and by rule designates as
being the principal compound commonly used or produced primarily for use, and
which is an immediate chemical intermediary used or likely to be used in the
manufacture of a controlled substance, the control of which is necessary to
prevent, curtail, or limit manufacture.
"Locum tenens practitioner" means a
practitioner who is licensed in this State and who temporarily substitutes for
another practitioner for a period not to exceed sixty days at that other
practitioner's registered place of business. Locum tenens practitioners are
not eligible to receive an oral code number as designated by section 328-16(k).
"Maintenance
treatment" means the dispensing
of a narcotic drug in the treatment of an individual for dependence upon heroin
or other morphine-like drug, for a period in excess of twenty-one days.
"Manufacture" means the production,
preparation, propagation, compounding, conversion, or processing of a
controlled substance, either directly or indirectly by extraction from
substances of natural origin, or independently by means of chemical synthesis,
or by a combination of extraction and chemical synthesis, and includes any
packaging or repackaging of the substance or labeling or relabeling of its
container, except that this term does not include the preparation or
compounding of a controlled substance by an individual for the individual's own
use or the preparation, compounding, packaging, or labeling of a controlled
substance:
(1) By a practitioner as
an incident to the practitioner's administering or dispensing of a controlled
substance in the course of the practitioner's professional practice, or
(2) By a practitioner, or
by the practitioner's authorized agent under the practitioner's supervision,
for the purpose of, or as an incident to, research, teaching, or chemical
analysis and not for sale.
"Marijuana" [Repeal and
reenactment on July 1, 2027. L 2023, c 263, §15.] means all parts
of the plant (genus) Cannabis whether growing or not; the seeds thereof, the
resin extracted from any part of the plant; and every compound, manufacture,
salt, derivative, mixture, or preparation of the plant, its seeds, or resin.
Marijuana shall not include:
(1) The mature stalks of
the plant (genus) Cannabis, fiber produced from the stalks, oil, or cake made
from the seeds of the plant, any other compound, manufacture, salt, derivative,
mixture, or preparation of the mature stalks (except the resin extracted therefrom),
fiber, oil, or cake, or the sterilized seed of the plant that is incapable of
germination;
(2) Hemp that is in the
possession, custody, or control of an individual or entity that holds a license
to produce hemp, issued by the Secretary of the United States Department of
Agriculture pursuant to title 7 United States Code section 1639q;
(3) Hemp that is in the
possession, custody, or control of a person or entity that is authorized under
state law to process hemp; and
(4) A product containing
or derived from hemp that:
(A) Does not
include any living hemp plants, viable seeds, leaf materials, or floral
materials; and
(B) Has a
delta-9-tetrahydrocannabinol concentration of not more than 0.3 per cent on a
dry weight basis, as measured post-decarboxylation or other similarly reliable
methods.
"Narcotic drug" means any of the
following, whether produced directly or indirectly by extraction from
substances of vegetable origin, or independently by means of chemical
synthesis, or by a combination of extraction and chemical synthesis:
(1) Opium and opiate, and
any salt, compound, derivative, or preparation of opium or opiate.
(2) Any salt, compound,
isomer, derivative, or preparation thereof which is chemically equivalent or
identical with any of the substances referred to in clause (1), but not
including the isoquinoline alkaloids of opium.
(3) Opium poppy and poppy
straw.
(4) Coca leaves and any
salt, compound, derivative, or preparation of coca leaves, and any salt,
compound, isomer, derivative, or preparation thereof which is chemically
equivalent or identical with any of these substances, but not including
decocainized coca leaves or extractions of coca leaves which do not contain
cocaine or ecgonine.
"Opiate" means any substance having
an addiction-forming or addiction-sustaining liability similar to morphine or
being capable of conversion into a drug having addiction-forming or
addiction-sustaining liability. It does not include, unless specifically
designated as controlled under section 329-11, the dextrorotatory isomer of
3-methoxy-n-methylmorphinan and its salts (dextromethorphan). It does include
its racemic and levorotatory forms.
"Opium poppy" means the plant of the
species Papaver somniferum, except its seeds.
"Person" means individual,
corporation, government, or governmental subdivision or agency, business trust,
estate, trust, partnership or association, or any other legal entity.
"Pharmacist" means a person who is
licensed or holds a permit under chapter 461 to practice pharmacy, including a
pharmacy intern who is under the immediate and direct supervision of a licensed
pharmacist.
"Pharmacy delegate" means an
individual employed by the pharmacy and selected by the pharmacist to act as
that pharmacist's agent to whom the pharmacist has delegated the task of
accessing electronic prescription accountability system information and for
whose actions the pharmacist takes full responsibility.
"Physician assistant" means a person
licensed under section 453-5.3, who is registered under this chapter to
administer, prescribe, or dispense a controlled substance under the authority
and supervision of a physician registered under section 329-33, but who is not
authorized to request, receive, or sign for professional controlled substance
samples.
"Physician-patient relationship"
means the collaborative relationship between physicians and their patients. To
establish this relationship, the treating physician or the physician's
designated member of the health care team, at a minimum shall:
(1) Personally perform a
face-to-face history and physical examination of the patient that is
appropriate to the specialty training and experience of the physician or the
designated member of the physician's health care team, make a diagnosis and
formulate a therapeutic plan, or personally treat a specific injury or
condition;
(2) Discuss with the
patient the diagnosis or treatment, including the benefits of other treatment
options; and
(3) Ensure the
availability of appropriate follow-up care.
"Poppy straw" means all parts, except
the seeds, of the opium poppy, after mowing.
"Practitioner" means:
(1) A physician, dentist,
veterinarian, scientific investigator, or other person licensed and registered
under section 329-32 to distribute, dispense, or conduct research with respect
to a controlled substance in the course of professional practice or research in
this State;
(2) An advanced practice
registered nurse with prescriptive authority licensed and registered under
section 329-32 to prescribe and administer controlled substances in the course
of professional practice in this State; and
(3) A pharmacy, hospital,
or other institution licensed, registered, or otherwise permitted to
distribute, dispense, conduct research with respect to or to administer a
controlled substance in the course of professional practice or research in this
State.
"Practitioner delegate" means an
agent or employee of a practitioner (physician, dentist, veterinarian, advanced
practice registered nurse with prescriptive authority, or physician assistant)
to whom the practitioner has delegated the task of accessing electronic
prescription accountability system information and for whose actions the
practitioner takes full responsibility.
"Prescribe" means to direct,
designate, or order the use of a formula for the preparation of a medicine for
a disease or illness and the manner of using them.
"Prescriber" means one who is
authorized to issue a prescription.
"Prescription" means an order for
medication, which is dispensed to or for an ultimate user.
"Prescription" shall not include an order for medication that is
dispensed for immediate administration to the ultimate user, such as a chart
order to dispense a drug to a bed patient for immediate administration in a
hospital.
"Production" includes the
manufacture, planting, cultivation, growing, or harvesting of a controlled
substance.
"Reverse distributor" means a
registrant who is registered under section 329-32 to receive controlled
substances acquired from another state certified controlled substance
registrant pursuant to title 21 Code of Federal Regulations part 1317, for the
purpose of:
(1) Returning unwanted,
unusable, or outdated controlled substances to the manufacturer or the
manufacturer's agent; or
(2) Where necessary,
processing such substances or arranging for the processing of such substances
for disposal as authorized by the administrator.
"State", when applied to a part of
the United States, includes any state, district, commonwealth, territory,
insular possession thereof, and any area subject to the legal authority of the
United States of America.
"Supervising physician" means a
physician licensed to practice medicine in the State and registered under
section 329-33, who supervises a physician assistant and retains full
professional and legal responsibility for the performance of the supervised
physician assistant and the care and treatment of the patient.
"System" means an electronic
prescription accountability system as described in part VIII.
"Ultimate user" means a person who
lawfully possesses a controlled substance for the person's own use or for the
use of a member of the person's household or for administering to an animal
owned by the person or by a member of the person's household.
[L 1972, c 10, pt
of §1; am L 1975, c 163, §7; gen ch 1985; am L 1986, c 214, §1; am L 1988, c
259, §1; am L 1989, c 293, §1; am L 1990, c 13, §1 and c 281, §§4, 10; am L
1991, c 159, §§3 to 6; am L 1996, c 268, §4; am L 1999, c 90, §1 and c 252, §1;
am L 2001, c 203, §1; am L 2004, c 44, §4; am L 2006, c 69, §2; am L 2008, c
186, §2; am L 2009, c 169, §6; am L 2010, c 57, §3; am L 2013, c 20, §2; am L
2016, c 218, §1; am L 2020, c 14, §§4, 9; am L 2022, c 63, §2, c 137, §2, and c
278, §17; am L 2023, c 111, §1]
